Company Filing History:
Years Active: 2011
Title: Mirna Tenan: Innovator in Glioma Treatment
Introduction
Mirna Tenan is a prominent inventor based in Geneva, Switzerland. She has made significant contributions to the field of medical research, particularly in the treatment of gliomas. Her innovative work focuses on the development of compounds that target specific proteins involved in cancer progression.
Latest Patents
Mirna Tenan holds a patent for "Junctional adhesion molecule-C (JAM-C) binding compounds and methods of their use." This invention relates to the use of a compound that specifically binds to JAM-C or JAM-B for the treatment of gliomas. More specifically, it involves the use of an antagonist of JAM-B or JAM-C for the treatment of glioma, particularly astrocytoma. She has 1 patent to her name.
Career Highlights
Mirna Tenan is currently associated with Merck Serono S.A., where she continues her research and development efforts. Her work has been instrumental in advancing therapeutic options for patients suffering from gliomas.
Collaborations
Throughout her career, Mirna has collaborated with esteemed colleagues, including Pierre-Yves Dietrich and Michel Aurrand-Lions. These partnerships have enhanced her research and contributed to the success of her innovative projects.
Conclusion
Mirna Tenan is a trailblazer in the field of glioma treatment, with her groundbreaking patent and collaborative efforts paving the way for future advancements in cancer therapy. Her contributions are vital to improving patient outcomes in the fight against gliomas.